Cholinergic muscarinic M1 and M4 receptors as therapeutic targets for cognitive, behavioural, and psychological symptoms in psychiatric and neurological disorders.
Saved in:
| Title: | Cholinergic muscarinic M |
|---|---|
| Authors: | Erskine D; Institute of Neuroscience, Newcastle University, Newcastle, UK. Electronic address: Daniel.erskine@ncl.ac.uk., Taylor JP; Institute of Neuroscience, Newcastle University, Newcastle, UK., Bakker G; Sosei Heptares, Cambridge, UK., Brown AJH; Sosei Heptares, Cambridge, UK., Tasker T; Sosei Heptares, Cambridge, UK., Nathan PJ; Sosei Heptares, Cambridge, UK; Department of Psychiatry, University of Cambridge, Cambridge, UK; School of Psychological Sciences, Monash University, Melbourne, VIC, Australia. Electronic address: Pradeep.nathan@soseiheptares.com. |
| Source: | Drug discovery today [Drug Discov Today] 2019 Dec; Vol. 24 (12), pp. 2307-2314. Date of Electronic Publication: 2019 Sep 06. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't; Review |
| Journal Info: | Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9604391 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-5832 (Electronic) Linking ISSN: 13596446 NLM ISO Abbreviation: Drug Discov Today Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
